Does a Positive Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screen Predict the Risk for MRSA Skin and

Allison M Hitchcock1, Robert W Seabury1, Wesley D Kufel1,2

  • 1Department of Pharmacy, Upstate University Hospital, Syracuse, NY, USA.

Abstract

Insights

MRSA nasal screening can help predict the risk of methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections (SSTIs). A positive screen significantly increases MRSA SSTI probability, while a negative screen slightly decreases it.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Epidemiology

Background:

  • Skin and soft tissue infections (SSTIs) are frequently caused by Gram-positive bacteria.
  • Antibiotic overuse has led to an increase in resistant pathogens, notably methicillin-resistant Staphylococcus aureus (MRSA).
  • Limited guidance exists on the effectiveness of MRSA nasal screening for predicting MRSA SSTIs.

Purpose of the Study:

  • To evaluate the predictive value of MRSA nasal screening for the development of MRSA SSTIs.
  • To determine if nasal colonization status correlates with the risk of SSTIs caused by MRSA.

Main Methods:

  • Retrospective cohort study of adult patients diagnosed with SSTI.
  • Inclusion criteria: MRSA nasal screening and wound cultures within 48 hours of antibiotic initiation.
  • Statistical analysis included sensitivity, specificity, predictive values, and likelihood ratios.

Main Results:

  • The study reviewed 884 patient encounters, including 300 in the final analysis.
  • MRSA SSTI prevalence was 18.3%.
  • MRSA nasal screening demonstrated a sensitivity of 63.6%, specificity of 93.9%, positive predictive value of 70.0%, and negative predictive value of 92.0%.

Conclusions:

  • A positive MRSA nasal screen significantly increases the likelihood of MRSA SSTI.
  • A negative MRSA nasal screen is associated with a decreased, though potentially significant, probability of MRSA SSTI.
  • Nasal MRSA screening provides valuable predictive information for MRSA SSTI risk assessment.